Recommanded Product: 1H-1,2,3-TriazoleIn 2021 ,《Current Trends in Enzyme Inhibition and Docking Analysis in Drug Design-Part-IV》 appeared in Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates). The author of the article were Geronikaki, Athina. The article conveys some information:
A review. In this review hybrids of 1,2,3-triazole scaffold with fluconazole, coumarines, benzimidazole/imidazoles, pyrazoles, oxiindole/indoles, chromene/pyranes, quinazoline, sugar, hetero/benzotriazoles are discussed. Docking methods, advances in the development of 1,2,3-triazole-containing derivatives as potential antifungal agents, and extensive review on tuberculosis. The docking methods, advances in the development of 1,2,3-triazole-containing derivatives as potential antifungal agents, and extensive review on tuberculosis. Hybridization of 1,2,3-triazole with other antimicrobial pharmacophores appears to be a judicious strategy to develop new efficacious anti-fungal candidates aiming at combating the emergence of drug-sensitive and drug-resistant infection disease. The docking of non-covalent small ligands, protein-protein docking, supercomputer docking, quantum docking, the new generation of the docking programs and the application of docking for covalent inhibitors discovery. The experimental part of the paper was very detailed, including the reaction process of 1H-1,2,3-Triazole(cas: 288-36-8Recommanded Product: 1H-1,2,3-Triazole)
1H-1,2,3-Triazole(cas: 288-36-8) belongs to triazoles. Triazoles are an important group of nitrogen-containing five-membered heterocyclic scaffolds. Triazoles are core structures of several drugs and pharmaceutical agents. Triazole derivatives possess antimicrobial, antiparasitic, antidiabetic, analgesic, and anti-inflammatory properties Recommanded Product: 1H-1,2,3-Triazole
Referemce:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics